The US cell counting market is estimated to grow significantly during the forecast period owing to due to several factors such as investments in R&D, high healthcare expenditure, the high prevalence of cancer and diabetes with significantly increased cell-based research. In addition, the state government of the nation has taken some initiatives for stem cell research in recent years that fuel the demand for a novel technique by a wide pool of patients diagnosed with cancer or diabetes. For instance, California Institute for Regenerative Medicine (CIRM) gives grants and provides loans for stem cell research, research facilities, and other research opportunities in the country.
The US market for cell counting is segregated on the basis of product type, application, and end-user. Based on product type, the market is further classified into instruments and consumables. The instrument segment growth is mainly driven by the increasing application of flow cytometers and hematology analyzers in cell accounting techniques. On the basis of application, the market is further segregated into medical applications, research, industrial. The medical application segment is estimated to hold a significant market share during the forecast period owing to the rising demand for cell counting techniques for noninvasive prenatal diagnosis. On the basis of end-user, the market for cell counting is further segmented into pharmaceuticals & biotechnology companies, research institutes & CROs, hospitals, and diagnostic laboratories.
The companies which are contributing to the growth of the US cell counting market include Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Danahar Corp., Thermo Fisher Scientific Inc., Perkinelmer, Inc., and others. Product launch, merger, and acquisition, collaborations with government, and technological advancements through which market players are considerably contributing to the market growth to stay competitive in the market.
Research Methodology
The market study of the US cell counting market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for cell counting solution providers, end-user companies for overall market analysis, and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. US Cell Counting Market by Product Type
4.1.1. Instruments
4.1.2. Consumables
4.2. US Cell Counting Market by Application
4.2.1. Medical Applications
4.2.2. Research
4.2.3. Industrial
4.3. US Cell Counting Market by End-User
4.3.1. Pharmaceuticals and Biotechnology companies
4.3.2. Research Institutes and CRO
4.3.3. Hospitals and Diagnostic Laboratories
5. Company Profiles
5.1. Abbott Laboratories
5.2. Agilent Technologies, Inc.
5.3. Becton, Dickinson and Co.
5.4. Bio-Rad Laboratories Inc.
5.5. Corning Inc.
5.6. Danahar Corp.
5.7. Luminex Corp.
5.8. Logos Biosystems, Inc.
5.9. Nexcelom Bioscience LLC
5.10. Olympus Corp.
5.11. Perkinelmer, Inc.
5.12. Sysmex Corp.
5.13. Thermo Fisher Scientific Inc.
1. US CELL COUNTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2019-2026 ($ MILLION)
2. US CELL COUNTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
3. US CELL COUNTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
1. US CELL COUNTING MARKET SHARE BY PRODUCT TYPE, 2019 VS 2026 (%)
2. US CELL COUNTING MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
3. US CELL COUNTING MARKET SHARE BY END-USER, 2019 VS 2026 (%)
4. US CELL COUNTING MARKET SIZE, 2019-2026 ($ MILLION)